SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!
苗条的从安
Lv1
10 积分
2024-07-12 加入
最近求助
最近应助
互助留言
Heterogeneity of Residual Disease After Neoadjuvant Systemic Therapy in Breast Cancer
9小时前
求助中
PARP Inhibitors for Breast Cancer Treatment
9小时前
已完结
Metastatic Hormone-Sensitive Prostate Cancer and Combination Treatment Outcomes
9小时前
已完结
First-line atezolizumab monotherapy versus single-agent chemotherapy in patients with non-small-cell lung cancer ineligible for treatment with a platinum-containing regimen (IPSOS): a phase 3, global, multicentre, open-label, randomised controlled study
15天前
已完结
Design and Rationale for a Phase III, Double-Blind, Placebo-Controlled Study of Neoadjuvant Durvalumab + Chemotherapy Followed by Adjuvant Durvalumab for the Treatment of Patients With Resectable Stages II and III non-small-cell Lung Cancer: The AEGEAN Trial
15天前
已完结
A global phase 3 study of serplulimab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (ASTRUM-004)
15天前
已完结
Efficacy of cetuximab plus PD-1 inhibitor differs by HPV status in head and neck squamous cell carcinoma: a systematic review and meta-analysis
28天前
已完结
The predictive role of PD-L1 in head and neck cancer: A systematic review and meta-analysis
1个月前
已完结
Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer
2个月前
已完结
Symptom and quality of life results of an international randomised phase III study of adjuvant vaccination with Bec2/BCG in responding patients with limited disease small-cell lung cancer
2个月前
已完结
没有进行任何应助
感谢
28天前
感谢
2个月前
感谢
2个月前
感谢
2个月前
感谢
2个月前
感谢
2个月前
感谢
2个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论